PL1968949T3 - Ulepszony sposób otrzymywania soli 4-(benzimidazolilometyloamino)-benzamidów - Google Patents

Ulepszony sposób otrzymywania soli 4-(benzimidazolilometyloamino)-benzamidów

Info

Publication number
PL1968949T3
PL1968949T3 PL06830756T PL06830756T PL1968949T3 PL 1968949 T3 PL1968949 T3 PL 1968949T3 PL 06830756 T PL06830756 T PL 06830756T PL 06830756 T PL06830756 T PL 06830756T PL 1968949 T3 PL1968949 T3 PL 1968949T3
Authority
PL
Poland
Prior art keywords
benzimidazolylmethylamino
benzamides
salts
preparation
improved process
Prior art date
Application number
PL06830756T
Other languages
English (en)
Inventor
Georg Zerban
Arndt Hausherr
Rainer Hamm
Gunter Koch
Kerstin Schlarb
Heinz-Peter Schmitt
Björn Weyell
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1968949T3 publication Critical patent/PL1968949T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL06830756T 2005-12-21 2006-12-20 Ulepszony sposób otrzymywania soli 4-(benzimidazolilometyloamino)-benzamidów PL1968949T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005061624A DE102005061624A1 (de) 2005-12-21 2005-12-21 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
PCT/EP2006/070034 WO2007071743A1 (en) 2005-12-21 2006-12-20 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
EP06830756A EP1968949B1 (en) 2005-12-21 2006-12-20 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides

Publications (1)

Publication Number Publication Date
PL1968949T3 true PL1968949T3 (pl) 2011-04-29

Family

ID=37950582

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06830756T PL1968949T3 (pl) 2005-12-21 2006-12-20 Ulepszony sposób otrzymywania soli 4-(benzimidazolilometyloamino)-benzamidów

Country Status (23)

Country Link
US (1) US7880016B2 (pl)
EP (1) EP1968949B1 (pl)
JP (1) JP5317702B2 (pl)
KR (1) KR101411961B1 (pl)
CN (1) CN101346355B (pl)
AR (1) AR058571A1 (pl)
AT (1) ATE485279T1 (pl)
AU (1) AU2006326980B2 (pl)
BR (1) BRPI0620150A2 (pl)
CA (1) CA2632310C (pl)
CY (1) CY1111113T1 (pl)
DE (2) DE102005061624A1 (pl)
DK (1) DK1968949T3 (pl)
ES (1) ES2355045T3 (pl)
IL (1) IL192242A (pl)
NZ (1) NZ569636A (pl)
PL (1) PL1968949T3 (pl)
PT (1) PT1968949E (pl)
RU (1) RU2425827C2 (pl)
SI (1) SI1968949T1 (pl)
TW (1) TWI411608B (pl)
WO (1) WO2007071743A1 (pl)
ZA (1) ZA200804198B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US8173906B2 (en) * 2007-02-07 2012-05-08 Raytheon Company Environmental protection coating system and method
US7767589B2 (en) * 2007-02-07 2010-08-03 Raytheon Company Passivation layer for a circuit device and method of manufacture
KR20100129281A (ko) * 2008-03-28 2010-12-08 베링거 인겔하임 인터내셔날 게엠베하 경구 투여되는 다비가트란 제형의 제조 방법
EP2300431B1 (en) * 2008-06-16 2016-01-06 Boehringer Ingelheim International GmbH Process for the manufacture of an intermediate in the synthesis of dabigatran
CN102066355B (zh) 2008-06-16 2015-07-01 贝林格尔.英格海姆国际有限公司 达比加群酯的中间体的制备方法
AU2009272796A1 (en) 2008-07-14 2010-01-21 Boehringer Ingelheim International Gmbh Method for manufacturing medicinal compounds containing dabigatran
EP2358368A1 (en) 2008-11-11 2011-08-24 Boehringer Ingelheim International GmbH Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
JP2013521318A (ja) * 2010-03-08 2013-06-10 ラティオファルム ゲー・エム・ベー・ハー ダビガトランエテキシラートを含有する医薬組成物
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
WO2013150545A2 (en) * 2012-04-02 2013-10-10 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
IN2015DN01414A (pl) * 2012-08-31 2015-07-03 Ranbaxy Lab Ltd
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
US9533971B2 (en) 2012-10-29 2017-01-03 Biophore India Pharmaceuticals Pvt. Ltd Process for the synthesis of dabigatran and its intermediates
CN103275065A (zh) * 2013-05-30 2013-09-04 上海同昌生物医药科技有限公司 一种新的生产达比加群酯的方法
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
US10112901B2 (en) 2014-07-03 2018-10-30 Shanghai Institute Of Pharmaceutical Industry Method for preparing dabigatran etexilate intermediate, and intermediate compound
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104987323B (zh) * 2015-07-10 2017-08-22 浙江美诺华药物化学有限公司 一种达比加群酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
DE19962329A1 (de) 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
EP1485094B2 (de) * 2002-03-07 2020-03-25 Boehringer Ingelheim International GmbH Oral zu applizierende darreichungsform für 3- [(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester oder dessen salze
NL1026498C2 (nl) * 2004-06-24 2005-12-28 Free Lift B V Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid.
EP1609784A1 (de) 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen

Also Published As

Publication number Publication date
DK1968949T3 (da) 2011-01-24
JP5317702B2 (ja) 2013-10-16
KR20080081179A (ko) 2008-09-08
AU2006326980A1 (en) 2007-06-28
SI1968949T1 (sl) 2011-02-28
JP2009520766A (ja) 2009-05-28
IL192242A0 (en) 2008-12-29
TWI411608B (zh) 2013-10-11
CY1111113T1 (el) 2015-06-11
CA2632310A1 (en) 2007-06-28
TW200740791A (en) 2007-11-01
RU2425827C2 (ru) 2011-08-10
DE102005061624A1 (de) 2007-06-28
KR101411961B1 (ko) 2014-06-27
ZA200804198B (en) 2009-04-29
ES2355045T3 (es) 2011-03-22
CN101346355A (zh) 2009-01-14
US20070185173A1 (en) 2007-08-09
RU2008129637A (ru) 2010-01-27
BRPI0620150A2 (pt) 2011-11-01
CN101346355B (zh) 2012-09-05
CA2632310C (en) 2014-02-11
AR058571A1 (es) 2008-02-13
US7880016B2 (en) 2011-02-01
WO2007071743A1 (en) 2007-06-28
EP1968949B1 (en) 2010-10-20
IL192242A (en) 2012-02-29
EP1968949A1 (en) 2008-09-17
AU2006326980B2 (en) 2012-07-05
NZ569636A (en) 2010-04-30
ATE485279T1 (de) 2010-11-15
DE602006017743D1 (de) 2010-12-02
PT1968949E (pt) 2010-12-22

Similar Documents

Publication Publication Date Title
ZA200804198B (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
IL192241A0 (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
IL190135A0 (en) Process for the preparation of pyrimidinedione derivatives
ZA200903533B (en) Process for the preparation of rosuvastatin
ZA200900551B (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
IL190666A0 (en) Process for the preparation of insulin conjugates
ZA200710914B (en) Process for the preparation of sulfonamide derivatives
IL196474A0 (en) Improved process for the preparation of voriconazole
SI1844036T1 (sl) Postopek za pripravo aripiprazola
EP1940793A4 (en) METHOD FOR PRODUCING MONTELUCASTS
EP2024369A4 (en) NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
IL185335A0 (en) Process for the preparation of substituted benzoxazole compounds
EP1893625A4 (en) PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
IL190325A (en) A process for making loopfin
ZA200601910B (en) Process for the preparation of organosilances
HUP0500537A3 (en) Process for the preparation of rosuvastatin via new intermediates
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
IL189574A0 (en) Process for preparing 1-substituted-5-acylimidazole compounds
PT1937662E (pt) Processo para a preparação de duloxetina
ZA200804778B (en) New process for the preparation of esomeprazole non-salt form
IL187660A0 (en) Process for the preparation of sulfonic acid salts of oxabispidines